Private Trust Company’s Takeda Pharmaceutical TAK Stock Holding History

Private Trust Company’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.4K	Sell	2,272 -102	-4%	-$1.69K	﹤0.01%	1529
2026 Q1	$44K	Buy	2,374 +667	+39%	+$11.7K	﹤0.01%	1363
2025 Q4	$26.6K	Buy	1,707 +783	+85%	+$11.2K	﹤0.01%	1535
2025 Q3	$13.5K	Sell	924 -111	-11%	-$1.65K	﹤0.01%	1794
2025 Q2	$16K	Hold	1,035	–	–	﹤0.01%	1659
2025 Q1	$15.4K	Buy	+1,035	New	+$14.5K	﹤0.01%	1657
2024 Q4	–	Sell	-268	Closed	-$3.81K	–	2408
2024 Q3	$3.81K	Sell	268 -169	-39%	-$2.4K	﹤0.01%	2039
2024 Q2	$5.66K	Hold	437	–	–	﹤0.01%	1881
2024 Q1	$6.07K	Sell	437 -45	-9%	-$654	﹤0.01%	1838
2023 Q4	$6.88K	Buy	482 +31	+7%	+$440	﹤0.01%	1804
2023 Q3	$6.98K	Hold	451	–	–	﹤0.01%	1743
2023 Q2	$7.08K	Hold	451	–	–	﹤0.01%	1760
2023 Q1	$7.43K	Sell	451 -23	-5%	-$366	﹤0.01%	1700
2022 Q4	$7K	Hold	474	–	–	﹤0.01%	1704
2022 Q3	$6K	Hold	474	–	–	﹤0.01%	1638
2022 Q2	$7K	Buy	+474	New	+$6.77K	﹤0.01%	1649

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Private Trust Company's TAK Position: Q2 2026 in Review

Private Trust Company reduced its Takeda Pharmaceutical (TAK) stake by 4.3% in Q2 2026, selling an estimated $1.69K and leaving 2,272 shares worth $36.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1529.

Private Trust Company first reported a position in TAK in Q2 2022 and has held it in 16 quarters since. The position peaked at $44K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Private Trust Company held 2,272 shares of Takeda Pharmaceutical worth $36.4K as of Q2 2026.
Private Trust Company sold 102 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.69K.
Takeda Pharmaceutical made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #1529 holding.
Private Trust Company first reported a position in Takeda Pharmaceutical in Q2 2022 and has held it in 16 quarters since.
Private Trust Company's Takeda Pharmaceutical position peaked at $44K in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.